Moraes, F. Y., Perry, L. A., Penny‐Dimri, J. C., Ramson, D., de Castria, T. B., Bowman, R. V., . . . Riera, R. (2017). Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) versus chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer. Cochrane Database Syst Rev.

Moraes, Fabio Y., Luke A. Perry, Jahan C. Penny‐Dimri, Dhruvesh Ramson, Tiago B. de Castria, Rayleen V. Bowman, Fábio N. Santos, Kwun M. Fong, and Rachel Riera. "Immune Checkpoint Inhibitors (anti PD‐1 or Anti PD‐L1) Versus Chemotherapy for Second‐ or Third‐line Treatment of Metastatic Non‐small Cell Lung Cancer." Cochrane Database Syst Rev 2017.

Moraes, Fabio Y., et al. "Immune Checkpoint Inhibitors (anti PD‐1 or Anti PD‐L1) Versus Chemotherapy for Second‐ or Third‐line Treatment of Metastatic Non‐small Cell Lung Cancer." Cochrane Database Syst Rev 2017.